| A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia I Gojo, JH Beumer, KW Pratz, MA McDevitt, MR Baer, AL Blackford, ... Clinical Cancer Research 23 (3), 697-706, 2017 | 69 | 2017 |
| Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti … S Voruganti, JJ Qin, S Sarkar, S Nag, IA Walbi, S Wang, Y Zhao, W Wang, ... Oncotarget 6 (25), 21379, 2015 | 65 | 2015 |
| Roflumilast protects from cisplatin-induced testicular toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line. Role of NF-κB-p65, cAMP/PKA and Nrf2/HO … BA Abdel-Wahab, IA Walbi, HA Albarqi, FEM Ali, EHM Hassanein Food and Chemical Toxicology 151, 112133, 2021 | 31 | 2021 |
| Development of a curcumin-loaded lecithin/chitosan nanoparticle utilizing a box-behnken design of experiment: formulation design and influence of process parameters IA Walbi, MZ Ahmad, J Ahmad, MS Algahtani, AS Alali, SA Alsudir, ... Polymers 14 (18), 3758, 2022 | 19 | 2022 |
| Microwave enabled physically cross linked sodium alginate and pectin film and their application in combination with modified chitosan-curcumin nanoparticles. A novel strategy … HM Basit, M Ali, MM Shah, SU Shah, A Wahab, HA Albarqi, AA Alqahtani, ... Polymers 13 (16), 2716, 2021 | 16 | 2021 |
| Exploitation of design-of-experiment approach for design and optimization of fast-disintegrating tablets for sublingual delivery of sildenafil citrate with enhanced … AS AlAli, MF Aldawsari, A Alalaiwe, BK Almutairy, R Al-Shdefat, IA Walbi, ... Pharmaceutics 13 (6), 870, 2021 | 13 | 2021 |
| In Vitro Cytotoxicity and Spectral Analysis-Based Phytochemical Profiling of Methanol Extract of Barleria hochstetteri, and Molecular Mechanisms Underlying Its … SA Alkahtani, AM Alshabi, IA Shaikh, MAA Orabi, BA Abdel-Wahab, ... Separations 9 (10), 298, 2022 | 10 | 2022 |
| Phytochemicals from Corchorus olitorius methanolic extract induce apoptotic cell death via activation of caspase-3, anti-Bcl-2 activity, and DNA degradation in breast and lung … AM Alshabi, SA Alkahtani, IA Shaikh, MAA Orabi, BA Abdel-Wahab, ... Journal of King Saud University-Science 34 (7), 102238, 2022 | 10 | 2022 |
| Piclamilast mitigates 1, 2-dimethylhydrazine induced colon cancer in rats through modulation of Ras/PI3K/Akt/mTOR and NF-κβ signaling BA Abdel-Wahab, H Alqhtani, IA Walbi, HA Albarqi, AM Aljadaan, ... Chemico-Biological Interactions 350, 109686, 2021 | 7 | 2021 |
| Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma HA Albarqi, A Garg, MZ Ahmad, AA Alqahtani, IA Walbi, J Ahmad Pharmaceutics 15 (2), 681, 2023 | 5 | 2023 |
| Physicochemical characterization of chitosan-decorated finasteride solid lipid nanoparticles for skin drug delivery M Sohaib, SU Shah, KU Shah, NR Khan, MM Irfan, ZR Niazi, ... BioMed Research International 2022, 2022 | 5 | 2022 |
| Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort IA Walbi, HA Albarqi, NS Alghanim, MA Albadi, HM Al Maimouni, ... Journal of International Medical Research 50 (4), 03000605221090363, 2022 | 5 | 2022 |
| Preparation, characterization and evaluation of flavonolignan silymarin effervescent floating matrix tablets for enhanced oral bioavailability S Ahmad, JA Khan, TN Kausar, MH Mahnashi, A Alasiri, AA Alqahtani, ... Molecules 28 (6), 2606, 2023 | 4 | 2023 |
| A Preliminary Cytotoxicity Study of Fagonia arabica against Breast (MCF-7), Oral (KB-3-1), and Lung Cancer (A-549) Cell Lines: A Study Supported by Molecular … IA Walbi, AM Alshabi, SA Alkahtani, IA Shaikh, BA Abdel-Wahab, ... Separations 10 (2), 110, 2023 | 4 | 2023 |
| Apoptotic Cell Death via Activation of DNA Degradation, Caspase-3 Activity, and Suppression of Bcl-2 Activity: An Evidence-Based Citrullus colocynthis Cytotoxicity … IA Shaikh, AM Alshabi, SA Alkahtani, MAA Orabi, BA Abdel-Wahab, ... Separations 9 (12), 411, 2022 | 4 | 2022 |
| Predicting hydroxychloroquine clearance in healthy and diseased populations using a physiologically based pharmacokinetic approach F Alqahtani, AM Asiri, A Zamir, MF Rasool, AS Alali, S Alsanea, IA Walbi Pharmaceutics 15 (4), 1250, 2023 | 2 | 2023 |
| The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia IA Walbi, H Alqhtani, F Alqahtani, SA Alkahtani, AM Alshabi, AS Alali, ... Saudi Pharmaceutical Journal 30 (7), 964-970, 2022 | 2 | 2022 |
| A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Leukemias I Gojo, JH Beumer, K Pratz, J Ji, L Wang, MA Rudek, MA McDevitt, ... Blood, The Journal of the American Society of Hematology 126 (23), 1361-1361, 2015 | 2 | 2015 |
| Nanoengineered chitosan functionalized titanium dioxide biohybrids for bacterial infections and cancer therapy M Shabib Akhtar, K Chandrasekaran, S Saminathan, SR Rajalingam, ... Scientific Reports 14 (1), 3705, 2024 | 1 | 2024 |
| Pharmacokinetics of the combination of veliparib and temozolomide in leukemia I Walbi University of Pittsburgh, 2014 | 1 | 2014 |
